Related Experiment Video
Updated: Jun 21, 2026

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
Published on: April 16, 2019
Dexamethasone in Cryptococcus gattii central nervous system infection
Peter Phillips1, Kristine Chapman, Madeleine Sharp
1Divisions of Infectious Diseases, St. Paul's Hospital, 1081 Burrard St., Rm. 667, Vancouver, BC V6Z 1Y6, Canada. pphillips@cfenet.ubc.ca
Dexamethasone showed favorable responses in 3 of 4 patients with Cryptococcus gattii central nervous system infections. Further evaluation of dexamethasone is suggested for this patient subset.
Area of Science:
- Infectious Diseases
- Neurology
- Pharmacology
Background:
- Cryptococcus gattii can cause central nervous system infections.
- Standard treatment guidelines do not recommend corticosteroids for cryptococcal meningitis.
- Some patients present with persistent neurological abnormalities despite standard care.
Purpose of the Study:
- To evaluate the clinical outcomes of dexamethasone in patients with Cryptococcus gattii CNS infection.
- To assess the efficacy of dexamethasone in managing persistent neurological deficits and brain lesions.
Main Methods:
- Retrospective review of 4 patients with Cryptococcus gattii CNS infection.
- Patients received dexamethasone for persistent mental status abnormalities and focal brain lesions.
- Cerebrospinal fluid cultures were negative, and intracranial pressure was managed.
Main Results:
- Three out of four patients experienced favorable clinical responses to dexamethasone.
- Dexamethasone appeared to help manage persistent neurological abnormalities and focal lesions.
- No adverse events related to dexamethasone were explicitly mentioned.
Conclusions:
- Dexamethasone may offer a therapeutic benefit in a subset of Cryptococcus gattii CNS infection patients.
- Further clinical trials are warranted to evaluate dexamethasone's role in treating these specific cases.
- This study suggests a potential adjunctive role for corticosteroids in refractory cases.
Related Concept Videos
Cryptococcal Meningitis
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Antifungal Agents
Cytomegalovirus Disease
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Candidiasis
